Related Experiment Video
Updated: Dec 24, 2025
08:48
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
3.3K
COVID-19: A Brief Overview of the Discovery Clinical Trial
1Formerly head of the Department of Organic Chemistry (FS), University of Mons-UMONS, 7000 Mons, Belgium.
Pharmaceuticals (Basel, Switzerland)
|April 16, 2020
Abstract:
The outbreak of COVID-19 is leading to a tremendous search for curative treatments. The urgency of the situation favors a repurposing of active drugs but not only antivirals. This short communication focuses on four treatments recommended by WHO and included in the first clinical trial of the European Discovery project.
Insights
The urgent search for COVID-19 treatments prioritizes drug repurposing. This study examines four World Health Organization-recommended treatments in the European Discovery clinical trial.
Area of Science:
- * Infectious Diseases
- * Pharmacology
- * Clinical Trials
Background:
- * The global COVID-19 pandemic necessitates rapid development of effective treatments.
- * Drug repurposing offers a faster alternative to novel drug discovery for urgent therapeutic needs.
- * Non-antiviral medications are also being explored for potential efficacy against SARS-CoV-2.
Purpose of the Study:
- * To evaluate four specific treatments recommended by the World Health Organization (WHO) for COVID-19.
- * To report on the inclusion of these treatments in the initial phase of the European Discovery clinical trial.
- * To contribute to the understanding of potential therapeutic options beyond antivirals.
Main Methods:
- * Focus on a short communication detailing selected treatments.
- * Inclusion in the European Discovery project's first clinical trial.
- * Review of WHO-recommended therapeutic strategies for COVID-19.
Main Results:
- * Four specific treatments were identified and included in the trial.
- * These treatments represent a diverse approach to managing COVID-19.
- * The study provides preliminary insights into the trial's selected interventions.
Conclusions:
- * The European Discovery trial is investigating promising repurposed drugs for COVID-19.
- * The selected treatments offer potential therapeutic avenues for the pandemic.
- * Further clinical data will elucidate the efficacy and safety of these interventions.
More Related Videos
Related Concept Videos
01:11Clinical Trials: Overview
4.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
01:16Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
01:28Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
01:26Drug Discovery: Overview
10.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.8K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
90
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
90
01:26Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K